1. Home
  2. MRNA vs DOCS Comparison

MRNA vs DOCS Comparison

Compare MRNA & DOCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • DOCS
  • Stock Information
  • Founded
  • MRNA 2010
  • DOCS 2010
  • Country
  • MRNA United States
  • DOCS United States
  • Employees
  • MRNA N/A
  • DOCS N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • DOCS Retail: Computer Software & Peripheral Equipment
  • Sector
  • MRNA Health Care
  • DOCS Technology
  • Exchange
  • MRNA Nasdaq
  • DOCS Nasdaq
  • Market Cap
  • MRNA 10.9B
  • DOCS 10.9B
  • IPO Year
  • MRNA 2018
  • DOCS 2021
  • Fundamental
  • Price
  • MRNA $25.87
  • DOCS $73.25
  • Analyst Decision
  • MRNA Hold
  • DOCS Buy
  • Analyst Count
  • MRNA 19
  • DOCS 19
  • Target Price
  • MRNA $43.50
  • DOCS $67.53
  • AVG Volume (30 Days)
  • MRNA 12.2M
  • DOCS 1.1M
  • Earning Date
  • MRNA 11-06-2025
  • DOCS 11-06-2025
  • Dividend Yield
  • MRNA N/A
  • DOCS N/A
  • EPS Growth
  • MRNA N/A
  • DOCS 45.79
  • EPS
  • MRNA N/A
  • DOCS 1.17
  • Revenue
  • MRNA $3,078,000,000.00
  • DOCS $589,636,000.00
  • Revenue This Year
  • MRNA N/A
  • DOCS $13.33
  • Revenue Next Year
  • MRNA $10.17
  • DOCS $10.90
  • P/E Ratio
  • MRNA N/A
  • DOCS $62.13
  • Revenue Growth
  • MRNA N/A
  • DOCS 19.45
  • 52 Week Low
  • MRNA $23.15
  • DOCS $39.62
  • 52 Week High
  • MRNA $75.37
  • DOCS $85.21
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 51.44
  • DOCS 71.70
  • Support Level
  • MRNA $23.18
  • DOCS $71.31
  • Resistance Level
  • MRNA $25.90
  • DOCS $73.10
  • Average True Range (ATR)
  • MRNA 1.16
  • DOCS 1.53
  • MACD
  • MRNA 0.27
  • DOCS 0.23
  • Stochastic Oscillator
  • MRNA 95.05
  • DOCS 96.67

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About DOCS Doximity Inc.

Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.

Share on Social Networks: